Alnylam Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. 

CEO
Yvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees
2,100
Employees2,100
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2002
Founded2002
Employees
2,100
Employees2,100

ALNY Key Statistics

Market cap
18.56B
Market cap18.56B
Price-Earnings ratio
-41.37
Price-Earnings ratio-41.37
Dividend yield
Dividend yield
Average volume
650.40K
Average volume650.40K
High today
$151.00
High today$151.00
Low today
$147.22
Low today$147.22
Open price
$150.45
Open price$150.45
Volume
442.50K
Volume442.50K
52 Week high
$218.88
52 Week high$218.88
52 Week low
$143.52
52 Week low$143.52

ALNY News

Yahoo Finance 6d
Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited ... - Yahoo Finance

Family Health History Road Trip highlights video Educational brochure about hereditary ATTR (hATTR) amyloidosis Hereditary ATTR (hATTR) amyloidosis family dis...

Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited ... - Yahoo Finance

Analyst ratings

70%

of 30 ratings
Buy
70%
Hold
30%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.